| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |